DMCCB Basel Symposium
«Targeting RNA by Small Molecules»
4th February 2021, Online Symposium
Program
10.30
Welcome and introduction
10.45
Kamal Azzaoui, Saverna Therapeutics, Basel, CH
«NMR Fragment Based Screening against RNAs: Examples of Successful Hit Finding Projects»
11.20
Michaela Frye, Deutsches Krebsforschungszentrum, Heidelberg, D
«Function of cytosine-5 RNA methylation in translation»
«Function of cytosine-5 RNA methylation in translation»
12.00
Lunch break and poster session
14.00
Oliver Rausch, Storm Therapeutics, Cambridge, UK
«Targeting Cancer with First-in-Class Inhibitors of the RNA m6A Methyltransferase METTL3»
«Targeting Cancer with First-in-Class Inhibitors of the RNA m6A Methyltransferase METTL3»
14.35
Amanda E. Hargrove, Duke University, Durham, US
«Modulating the Conformation and Function of Disease-Relevant RNA with Small Molecules»
«Modulating the Conformation and Function of Disease-Relevant RNA with Small Molecules»
15.10
Break
15.30
Iris Alroy, Anima Biotech, Bernardsville, US
«Targeting mRNA translation in drug discovery without "shooting the messenger"»
16.05
Matthew Disney, Scripps Research Institute, Florida, US
«Sequence-Based Design of Small Molecules Targeting RNA»
16.40
Poster prizes and closing remarks
17.00
End of Symposium